PMID- 30847355 OWN - NLM STAT- MEDLINE DCOM- 20200218 LR - 20200309 IS - 2328-9503 (Print) IS - 2328-9503 (Electronic) IS - 2328-9503 (Linking) VI - 6 IP - 2 DP - 2019 Feb TI - Retinal measurements predict 10-year disability in multiple sclerosis. PG - 222-232 LID - 10.1002/acn3.674 [doi] AB - OBJECTIVE: Optical coherence tomography (OCT)-derived measures of the retina correlate with disability and cortical gray matter atrophy in multiple sclerosis (MS); however, whether such measures predict long-term disability is unknown. We evaluated whether a single OCT and visual function assessment predict the disability status 10 years later. METHODS: Between 2006 and 2008, 172 people with MS underwent Stratus time domain-OCT imaging [160 with measurement of total macular volume (TMV)] and high and low-contrast letter acuity (LCLA) testing (n = 150; 87%). All participants had Expanded Disability Status Scale (EDSS) assessments at baseline and at 10-year follow-up. We applied generalized linear regression models to assess associations between baseline TMV, peripapillary retinal nerve fiber layer (pRNFL) thickness, and LCLA with 10-year EDSS scores (linear) and with clinically significant EDSS worsening (binary), adjusting for age, sex, optic neuritis history, and baseline disability status. RESULTS: In multivariable models, lower baseline TMV was associated with higher 10-year EDSS scores (mean increase in EDSS of 0.75 per 1 mm(3) loss in TMV (mean difference = 0.75; 95% CI: 0.11-1.39; P = 0.02). In analyses using tertiles, individuals in the lowest tertile of baseline TMV had an average 0.86 higher EDSS scores at 10 years (mean difference = 0.86; 95% CI: 0.23-1.48) and had over 3.5-fold increased odds of clinically significant EDSS worsening relative to those in the highest tertile of baseline TMV (OR: 3.58; 95% CI: 1.30-9.82; P (trend )= 0.008). pRNFL and LCLA predicted the 10-year EDSS scores only in univariate models. INTERPRETATION: Lower baseline TMV measured by OCT significantly predicts higher disability at 10 years, even after accounting for baseline disability status. FAU - Rothman, Alissa AU - Rothman A AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Murphy, Olwen C AU - Murphy OC AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Fitzgerald, Kathryn C AU - Fitzgerald KC AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Button, Julia AU - Button J AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Gordon-Lipkin, Eliza AU - Gordon-Lipkin E AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Ratchford, John N AU - Ratchford JN AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Newsome, Scott D AU - Newsome SD AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Mowry, Ellen M AU - Mowry EM AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Sotirchos, Elias S AU - Sotirchos ES AUID- ORCID: 0000-0002-8812-1637 AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Syc-Mazurek, Stephanie B AU - Syc-Mazurek SB AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Nguyen, James AU - Nguyen J AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Caldito, Natalia Gonzalez AU - Caldito NG AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Balcer, Laura J AU - Balcer LJ AD - Department of Neurology New York University Langone Medical Center New York New York. FAU - Frohman, Elliot M AU - Frohman EM AD - Department of Neurology and Ophthalmology Dell Medical School University of Texas Austin Austin Texas. FAU - Frohman, Teresa C AU - Frohman TC AD - Department of Neurology and Ophthalmology Dell Medical School University of Texas Austin Austin Texas. FAU - Reich, Daniel S AU - Reich DS AD - Department of Neurology Johns Hopkins University Baltimore Maryland. AD - Translational Neuroradiology Unit National Institutes of Health Bethesda Maryland. AD - Department of Biostatistics Johns Hopkins University Baltimore Maryland. FAU - Crainiceanu, Ciprian AU - Crainiceanu C AD - Department of Biostatistics Johns Hopkins University Baltimore Maryland. FAU - Saidha, Shiv AU - Saidha S AD - Department of Neurology Johns Hopkins University Baltimore Maryland. FAU - Calabresi, Peter A AU - Calabresi PA AUID- ORCID: 0000-0002-7776-6472 AD - Department of Neurology Johns Hopkins University Baltimore Maryland. LA - eng GR - R01 NS060910/NS/NINDS NIH HHS/United States GR - R01 NS082347/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20190119 PL - United States TA - Ann Clin Transl Neurol JT - Annals of clinical and translational neurology JID - 101623278 MH - Adult MH - Atrophy/complications/physiopathology MH - Disease Progression MH - Female MH - Humans MH - Male MH - Multiple Sclerosis/complications/*physiopathology MH - Optic Neuritis/complications/*physiopathology MH - Retina/pathology/*physiopathology MH - Retinal Ganglion Cells/*pathology MH - Tomography, Optical Coherence/methods PMC - PMC6389740 COIS- A.R., O.C.M., K.F., E.G.L., J.R., E.M., E.S.S., S.B.S.M., J.N., N.G.C., D.R., and C.C has nothing to report. S.D.N. has received consultant fees for scientific advisory boards from Biogen, Genentech, Celgene, EMD Serono and has received research funding from Biogen, Novartis, and Genentech (paid directly to institution). L.J.B. has received consulting fees from Biogen. E.F. has received speaker and consulting fees from Genzyme, Acorda, Novartis, and TEVA. T.F. has received speaker and consulting fees from Acorda, Genzyme, and Novartis. S.S. has received consulting fees from Medical Logix for the development of CME programs in neurology, consulting fees from Axon Advisors LLC and served on scientific advisory boards for Biogen-Idec, Genzyme, Genentech Corporation & Novartis. He receives research support from Genentech Corporation and Biogen Idec, and received support from the Race to Erase MS foundation. P.A.C. has received personal honorariums for consulting from Biogen and Disarm Therapeutics. He is PI on research grants to Johns Hopkins from MedImmune, Annexon, Biogen, and Genzyme. EDAT- 2019/03/09 06:00 MHDA- 2019/03/09 06:01 PMCR- 2019/01/19 CRDT- 2019/03/09 06:00 PHST- 2018/07/24 00:00 [received] PHST- 2018/08/30 00:00 [revised] PHST- 2018/09/27 00:00 [accepted] PHST- 2019/03/09 06:00 [entrez] PHST- 2019/03/09 06:00 [pubmed] PHST- 2019/03/09 06:01 [medline] PHST- 2019/01/19 00:00 [pmc-release] AID - ACN3674 [pii] AID - 10.1002/acn3.674 [doi] PST - epublish SO - Ann Clin Transl Neurol. 2019 Jan 19;6(2):222-232. doi: 10.1002/acn3.674. eCollection 2019 Feb.